等待開盤 11-04 09:30:00 美东时间
+1.900
+3.32%
今日重点评级关注:Ascendiant Capital:维持NRX Pharmaceuticals"买入"评级,目标价从50美元升至51美元;HC Wainwright & Co.:上调伊诺维奥制药评级至"买入",目标价5美元
11-03 18:20
Truist Securities analyst Youssef Squali maintains Cimpress (NASDAQ:CMPR) with a Buy and lowers the price target from $108 to $90.
11-02 23:57
Cimpress 2027 财年第一季度营收增长 8% 至 9.34 亿美元,而调整后 EBITDA 下降 9%。管理层维持了 2027 财年业绩指引,并加快了成本削减进程。
10-29 21:56
Cimpress (NASDAQ:CMPR) FY2027 Revenue expected to be more than $3.999B vs $4.008B Est
10-29 04:36
10月27日,Cimpress N.V - Ordinary Shares (The Netherlands)(CMPR)收涨1.98%,报82美元,成交额1...
10-27 05:27
10月20-22日上海黄浦江畔,2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势,更有“解救”焦虑、内卷时代的网红教授——麦克法兰与...
10-17 05:30
今日重点评级关注:TD Cowen:维持加拿大鹅"买入"评级,目标价从13美元升至18美元;瑞银:维持吉登运动服"买入"评级,目标价从110美元升至111美元
08-03 11:38
Truist Securities analyst Youssef Squali maintains Cimpress (NASDAQ:CMPR) with a Buy and lowers the price target from $110 to $108.
07-31 21:09
Cimpress shares are trading lower after the company reported worse-than-expected Q4 financial results.
07-30 04:35
Cimpress (NASDAQ:CMPR) reported quarterly earnings of $0.97 per share which missed the analyst consensus estimate of $1.22 by 20.49 percent. This is a 195.1 percent increase over losses of $(1.02) per share from the same period last year. The company reported quarterly sales of $944.955 million whic...
07-30 04:09